Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain activ... Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression and neurodegenerative disorders by using peptide-based and brain active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. Mehr anzeigen
NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0511 | -11.1183637946 | 0.4596 | 0.4625 | 0.4 | 53338 | 0.41650217 | CS |
| 4 | -0.0774 | -15.9292035398 | 0.4859 | 0.619 | 0.4 | 183258 | 0.51661521 | CS |
| 12 | -0.2215 | -35.1587301587 | 0.63 | 1.09 | 0.4 | 298094 | 0.62812186 | CS |
| 26 | -0.3015 | -42.4647887324 | 0.71 | 1.1099 | 0.4 | 256231 | 0.73617744 | CS |
| 52 | -0.4617 | -53.056768559 | 0.8702 | 1.87 | 0.4 | 135854 | 0.76334582 | CS |
| 156 | -3.7115 | -90.0849514563 | 4.12 | 4.92 | 0.4 | 64116 | 1.3979277 | CS |
| 260 | -14.5515 | -97.2693850267 | 14.96 | 19.56 | 0.4 | 341844 | 10.31799843 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
